Aed's biological: net profit in 2025 was 361 million yuan, an increase of 41.74% year-on-year.

Ed Bio announced that its operating income in 2025 was 1.198 billion yuan, an increase of 8.01% year-on-year. Net profit was 361 million yuan, an increase of 41.74% year-on-year. The profit distribution plan approved by the board of directors is as follows: based on the total share capital on the record date for the equity distribution plan for 2025, cash dividends of 4.5 yuan will be distributed to all shareholders for every 10 shares, no bonus shares will be issued, and no new shares will be issued from capital reserve to all shareholders for every 10 shares.